Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.76 |
| ▸ | CNR2 | P34972 | 3/20 | 0.76 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.76 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.76 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.76 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.76 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.76 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.76 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 0.76 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.76 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 0.76 |
| ▸ | PPARG | P37231 | 2/20 | 0.76 |
| ▸ | INHA | P05111 | 1/20 | 0.76 |
| ▸ | HTR2A | P28223 | 1/20 | 0.76 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.76 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.76 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.73 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25214476 | 0.90 | CNR1 (0.76) | CNR1CNR2TRPV1SLC6A3TRPA1 | |
| SCHEMBL25267536 | 0.90 | CNR1 (0.76) | CNR1CNR2TRPV1SLC6A3TRPA1 | |
| Cannabigerol SCHEMBL144819 | 0.87 | PPARG (1.00) | CNR1CNR2TRPV1SLC6A3TRPA1 | |
| Cannabigerol SCHEMBL12954626 | 0.87 | PPARG (1.00) | CNR1CNR2TRPV1SLC6A3TRPA1 | |
| Cannabigerol SCHEMBL14764730 | 0.87 | PPARG (1.00) | CNR1CNR2TRPV1SLC6A3TRPA1 | |
| SCHEMBL23522965 | 0.86 | PPARG (0.97) | CNR1CNR2TRPV1SLC6A3TRPA1 | |
| SCHEMBL23523543 | 0.86 | PPARG (0.97) | CNR1CNR2TRPV1SLC6A3TRPA1 | |
| SCHEMBL23523643 | 0.86 | PPARG (0.97) | CNR1CNR2TRPV1SLC6A3TRPA1 | |
| SCHEMBL23523451 | 0.86 | PPARG (0.97) | CNR1CNR2TRPV1SLC6A3TRPA1 | |
| SCHEMBL23523642 | 0.86 | PPARG (0.97) | CNR1CNR2TRPV1SLC6A3TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4565218-A1 | BIOSYNTHESIS OF SUBSTITUTED COMPOUNDS AND CANNABINOIDS | Invizyne Technologies, Inc. (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-12180516-B2 | Biosynthetic platform for the production of cannabinoids and other prenylated compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-12-31 | — | — | US | disclosed |
| US-20240076699-A1 | BIOSYNTHESIS OF SUBSTITUTED COMPOUNDS AND CANNABINOIDS | INVIZYNE TECHNOLOGIES, INC. (US) | 2024-03-07 | — | — | US | disclosed |
| WO-2024030866-A1 | BIOSYNTHESIS OF SUBSTITUTED COMPOUNDS AND CANNABINOIDS | INVIZYNE TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | WO | disclosed |
| US-20230193221-A1 | BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-06-22 | — | — | US | disclosed |
| US-11479760-B2 | Biosynthetic platform for the production of cannabinoids and other prenylated compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-10-25 | — | — | US | disclosed |
| US-20210276936-A1 | Synthesis of Cannabigerol | TREEHOUSE BIOTECH, INC. | 2021-09-09 | — | — | US | disclosed |
| US-11040932-B2 | Synthesis of cannabigerol | TREEHOUSE BIOTECH, INC. (US) | 2021-06-22 | — | — | US | disclosed |
| US-20200115306-A1 | SYNTHESIS OF CANNABIGEROL | TREEHOUSE BIOTECH, INC. | 2020-04-16 | — | — | US | disclosed |
| EP-0279308-B1 | Fluorescence polarization immunoassay for tetrahydrocannabinoids | ABBOTT LAB (US) | 1996-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115306-A1 | SYNTHESIS OF CANNABIGEROL | COASY, ACSL3, SQLE | CNR1 76/4885CNR2 27/4885TRPV1 1588/4885 |
| US-11040932-B2 | Synthesis of cannabigerol | COASY, ACSL3, SQLE | CNR1 76/4885CNR2 27/4885TRPV1 1588/4885 |
| US-20210276936-A1 | Synthesis of Cannabigerol | COASY, ACSL3, SQLE | CNR1 76/4885CNR2 27/4885TRPV1 1588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.